Edgar Filing: ALLIED HEALTHCARE PRODUCTS INC

OMB APPROVAL
--------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response....15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13D

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 8)*
---

ALLIED HEALTHCARE PRODUCTS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)

COMMON STOCK
--------------------------------------------------------------------------------
(Title of Class of Securities)

019222 10 8
--------------------------------------------------------------------------------
(CUSIP Number)

JOHN D. WEIL
200 N. BROADWAY
SUITE 825
ST. LOUIS, MISSOURI 63102
(314) 421-4600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

FEBRUARY 10, 2004
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. / /

NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

PERSONS WHO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE
NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL
NUMBER.

SEC 1746 (11-03)

CUSIP No. 019222 10 8 13D Page 2 of 5 Pages
--------------------------------------------------------------------------------
1. Names Of Reporting Persons.
I.R.S. Identification Nos. of Above Persons (Entities Only).

WOODBOURNE PARTNERS, L.P.
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)

(b)

--------------------------------------------------------------------------------
3. SEC Use Only

--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)

OO
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) OR 2(e)

--------------------------------------------------------------------------------
6. Citizenship or Place of Organization

MISSOURI
--------------------------------------------------------------------------------
7. Sole Voting Power
Number of
2,637,000
Shares -----------------------------------------------------------------
8. Shared Voting Power
Beneficially
-0-
Owned by Each -----------------------------------------------------------------
9. Sole Dispositive Power
Reporting
2,637,000
Person -----------------------------------------------------------------
10. Shared Dispositive Power
With
-0-
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person

2,637,000
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions)

--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)

33.7%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)

PN
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

CUSIP No. 019222 10 8 13D Page 3 of 5 Pages
--------------------------------------------------------------------------------
1. Names Of Reporting Persons.
I.R.S. Identification Nos. of Above Persons (Entities Only).

JOHN D. WEIL
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)

(b)

--------------------------------------------------------------------------------
3. SEC Use Only

--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)

OO
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) OR 2(e)

--------------------------------------------------------------------------------
6. Citizenship or Place of Organization

UNITED STATES
--------------------------------------------------------------------------------
7. Sole Voting Power
Number of
2,663,000, subject to the disclaimer in Item 5.
Shares -----------------------------------------------------------------
8. Shared Voting Power
Beneficially
26,300, subject to the disclaimer in Item 5.
Owned by Each -----------------------------------------------------------------
9. Sole Dispositive Power
Reporting
2,663,000, subject to the disclaimer in Item 5.
Person -----------------------------------------------------------------
10. Shared Dispositive Power
With
26,300, subject to the disclaimer in Item 5.
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person

2,689,300, subject to the disclaimer in Item 5.
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions)

--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)

34.2%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)

IN
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 4 of 5 Pages
--------------------------------------------------------------------------------

AMENDMENT NO. 7 TO SCHEDULE 13D

John D. Weil reported the acquisition of shares of Common Stock
("Stock") of Allied Healthcare Products, Inc., a Delaware corporation (the
"Issuer"), in an initial filing of this Schedule 13D on August 21, 1996, as
amended by Amendment No. 1 filed September 5 1996, Amendment No. 2 filed October
28, 1996, Amendment No. 3 filed May 28, 1997, Amendment 4 filed May 11, 1998,
Amendment No. 5 filed December 14, 1999, Amendment No. 6 filed November 30,
2000; and Amendment No. 7 filed May 22, 2003. As reported in Amendment No. 3
filed May 28, 1997, all shares of Stock previously reported as beneficially
owned by Mr. Weil, members of his family (other than Shares of Stock reported in
Item 5 as held by Mr. Weil's son), family trusts or the partnership controlled
by Mr. Weil were transferred to Woodbourne Partners, L.P. (the "Reporting
Person").

The Cover Pages for Mr. Weil and for Woodbourne Partners, L.P. are
hereby amended as shown in this Amendment No. 8. Items 4, 5 and 6 are hereby
amended as follow. All other items are unchanged from the initial filing, as
previously amended.

ITEM 4. Purpose of the Transaction.

The owners listed in Item 5 purchased the Stock of the Issuer for
general investment purposes. The owners listed in Item 5 may acquire additional
shares of the Stock of the Issuer, based upon their respective investment
decisions.

In August of 1997, Mr. Weil was elected to the Board of Directors of
the Issuer and presently serves as the non-executive Chairman of the Board of
Directors of the Issuer.

ITEM 5. Interest in Securities of the Issuer.

(a) Subject to the disclaimer of beneficial ownership hereinafter
set forth, the Reporting Person hereby reports beneficial
ownership of 1,429,500 shares of Stock in the manner
hereinafter described:

Percentage of
Relationship to Number of Outstanding
Shares Held in Name of Reporting Person Shares Securities
---------------------- ---------------- --------- -------------

Woodbourne Partners L.P. Reporting Person 2,637,000 33.7%

John D. Weil Sole Director and Shareholder of the 52,300(1)(2) 0.7%
General Partner of the Reporting Person

TOTAL 2,689,300 34.7%
========= =====

Notes:

(1) Includes 9,250 shares held directly, 4,000 shares held indirectly, 26,300
shares held by the spouse of John D. Weil, and 12,750 shares deemed beneficially
owned as the result of options held by John D. Weil exercisable currently or
within 60 days.

(2) Does not include 10,000 shares held by an adult son of John D. Weil or 9,000
shares held by an Individual Retirement Account for the benefit of a person
holding a limited partnership interest in Woodbourne Partners L.P.

The foregoing percentages assume that the Issuer has 7,813,932 shares of
Stock outstanding as of February 13, 2004.

--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 5 of 5 Pages
--------------------------------------------------------------------------------

AS PROVIDED IN S.E.C. REGULATION ss.240.13d-4, JOHN D. WEIL HEREBY DECLARES
THAT THIS STATEMENT SHALL NOT BE CONSTRUED AS AN ADMISSION THAT HE IS, FOR THE
PURPOSES OF SECTION 13(d) OR 13(g) OF THE SECURITIES EXCHANGE ACT, THE
BENEFICIAL OWNER OF THE SECURITIES HELD BY HIS SPOUSE OR THE REPORTING PERSON
COVERED BY THIS STATEMENT.

(b) Subject to the above disclaimer of beneficial ownership, for each
person named in paragraph (a), the number of shares as to which
there is sole power to vote or direct the vote, shared power to vote
or direct the vote, sole power to dispose or direct the disposition,
or shared power to dispose or direct the disposition, is the same as
in paragraph (a).

(c)

Number Net Price Transaction
Purchase/(Sale) in the Name of Date of Shares Per Share Made Through
------------------------------ -------- --------- --------- --------------------

Woodbourne Partners, L.P. 10/01/03 25,000 3.00 Huntleigh Securities
Woodbourne Partners, L.P. 10/03/03 20,500 3.00 Huntleigh Securities
John D. Weil 12/11/03 4,500 2.44* Option Exercises
Woodbourne Partners, L.P. 2/10/04 60,000 3.75 Huntleigh Securities
Woodbourne Partners, L.P. 2/24/04 18,600 4.35 Huntleigh Securities

* 2,500 shares at $1.875; 1,000 shares at $2.90; and 1,000 shares at $3.40.

(d) Not applicable.

(e) Not applicable.

ITEM 6. Contracts, Arrangements, Understandings or Relationships With Respect
to Securities of the Issuer.

In August of 1997, Mr. Weil was elected to the Board of Directors of
the Issuer and presently serves as the non-executive Chairman of the Board of
Directors of the Issuer. As a director of the Issuer, Mr. Weil has received
options to acquire shares of the Issuer's Stock pursuant to the "Directors
Non-Qualified Option Plan" maintained by the Issuer (the "Plan").

After reasonable inquiry, and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

WOODBOURNE PARTNERS, L.P.,

by its General Partner,
CLAYTON MANAGEMENT COMPANY

/s/ John D. Weil
--------------------------------
John D. Weil, President

JOHN D. WEIL

/s/ John D. Weil
---------------------------------

February 25, 2004